| ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate NG Amôr, CE de Oliveira, TH Gasparoto, VGV Boas, G Perri, R Kaneno, ... Oncotarget 9 (56), 30894, 2018 | 26 | 2018 |
| Fcγ receptors on aging neutrophils TH Gasparoto, TM Dalboni, NG Amôr, AE Abe, G Perri, VS Lara, NA Vieira, ... Journal of Applied Oral Science 29, e20200770, 2021 | 20 | 2021 |
| Phenotypic plasticity-alternate transcriptional programs driving treatment resistant prostate cancer JS Nanda, P Koganti, G Perri, L Ellis Critical Reviews™ in Oncogenesis 27 (1), 2022 | 9 | 2022 |
| Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation G Perri, VG Vilas Boas, MRS Nogueira, EJF Mello Júnior, AL Coelho, ... Cancer Immunology, Immunotherapy 73 (6), 1-11, 2024 | 2 | 2024 |
| 309 Serum markers of disease activity correlate with pain perception in systemic lupus erythematosus patients KL Yee, L Huo, G Perri, L Forbess, S Venuturupalli, M Ishimori, ... Lupus Science & Medicine 11 (Suppl 2), 2024 | | 2024 |
| Loss of TRIM21 drives UVB-induced systemic inflammation by regulating DNA-sensing pathways G Tumurkhuu, R Moore, G Perri, G De Los Santos, DE Laguna, D Gibb, ... bioRxiv, 2024.04. 10.588897, 2024 | | 2024 |
| Efeito de IL-33 e do meio condicionado de macrófagos na ativação de células tumorais G Perri Universidade de São Paulo, 2021 | | 2021 |
| Análise do desenvolvimento de carcinoma espinocelular de pele GFF Silva, VG Vilas Boas, G Perri, AP Campanelli Anais, 2018 | | 2018 |
| Presença de IL33 em amostras de carcinoma espinocelular G Perri Universidade de São Paulo, 2016 | | 2016 |
